Die Aortenklappeninsuffizienz – können wir mit interventionellen Therapieoptionen mehr Patienten helfen?

Zusammenfassung

Die hochgradige, symptomatische Aortenklappeninsuffizienz ist häufig nicht einfach zu diagnostizieren und bei einem relevanten Anteil der Patienten noch nicht ausreichend gut behandelt. Dabei können auch Patienten mit höherem operativen Risiko von einem Aortenklappenersatz profitieren. Durch das Fortschreiten der interventionellen Therapieoptionen stellt die Transkatheter-Aortenklappenimplantation (TAVI) mittlerweile eine ebenfalls zu berücksichtigende Therapieoption dar. Dadurch kann es möglich werden, auch ältere und kränkere Patienten einer adäquaten und notwendigen Therapie der Aortenklappeninsuffizienz zuzuführen.

Abstract

Severe symptomatic aortic valve regurgitation is often not easy to diagnose and in a relevant proportion of patients it is not yet sufficiently well treated. In this context, patients at higher surgical risk may also benefit from aortic valve replacement. With the advancement of interventional therapy options, transcatheter aortic valve implantation (TAVI) is now a therapeutic option that should also be considered. This may make it possible to provide older and sicker patients with adequate and necessary therapy for aortic valve insufficiency.

Was ist wichtig?

• Die Diagnosestellung einer hochgradigen, symptomatischen Aortenklappeninsuffizienz ist häufig komplex und schwierig.

• Auch Patienten mit höherem operativem Risiko können von einem Aortenklappenersatz profitieren.

• Die Transkatheter-Aortenklappenimplantation (TAVI) stellt mittlerweile eine ebenfalls zu berücksichtigende Therapieoption der Aortenklappeninsuffizienz bei älteren und kränkeren Patienten dar.

Schlüsselwörter

Aortenklappeninsuffizienz - TAVI - Aortenklappenersatz

Keywords

aortic regurgitation - TAVR - aortic valve replacement

Publication History

Article published online:
05 October 2022

• Literatur

• 1 Iung B, Baron G, Butchart EG. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243 DOI: 10.1016/s0195-668x(03)00201-x. (PMID: 12831818)
• 2 Nkomo VT, Gardin JM, Skelton TN. et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-1011 DOI: 10.1016/S0140-6736(06)69208-8. (PMID: 16980116)
• 3 Singh JP, Evans JC, Levy D. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83: 897-902 DOI: 10.1016/s0002-9149(98)01064-9. (PMID: 10190406)
• 4 Roberts WC, Ko JM, Moore TR. et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006; 114: 422-429 DOI: 10.1161/circulationaha.106.622761. (PMID: 16864725)
• 5 Bonow RO. Chronic mitral regurgitation and aortic regurgitation: have indications for surgery changed?. J Am Coll Cardiol 2013; 61: 693-701 DOI: 10.1016/j.jacc.2012.08.1025. (PMID: 23265342)
• 6 Dujardin KS, Enriquez-Sarano M, Schaff HV. et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999; 99: 1851-1857 DOI: 10.1161/01.cir.99.14.1851. (PMID: 10199882)
• 7 Evangelista A, Tornos P, Sambola A. et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005; 353: 1342-1349 DOI: 10.1056/NEJMoa050666. (PMID: 16192479)
• 8 Broch K, Urheim S, Lønnebakken MT. et al. Controlled release metoprolol for aortic regurgitation: a randomised clinical trial. Heart 2016; 102: 191-197 DOI: 10.1136/heartjnl-2015-308416. (PMID: 26661319)
• 9 Vahanian A, Beyersdorf F, Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561-632 DOI: 10.1093/eurheartj/ehab395. (PMID: 34453165)
• 10 Thourani VH, Brennan JM, Edelman JJ. et al. Treatment Patterns, Disparities, and Management Strategies Impact Clinical Outcomes in Patients with Symptomatic Severe Aortic Regurgitation. Structural Heart 2021; 5: 608-618 DOI: 10.1080/24748706.2021.1988779.
• 11 Roy DA, Schaefer U, Guetta V. et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 2013; 61: 1577-1584 DOI: 10.1016/j.jacc.2013.01.018. (PMID: 23433565)
• 12 Testa L, Latib A, Rossi ML. et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention 2014; 10: 739-745 DOI: 10.4244/eijv10i6a127. (PMID: 25330506)
• 13 Anwaruddin S, Desai ND, Szeto WY. et al. Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry). Am J Cardiol 2019; 124: 781-788 DOI: 10.1016/j.amjcard.2019.05.045. (PMID: 31311661)
• 14 Yoon SH, Schmidt T, Bleiziffer S. et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. J Am Coll Cardiol 2017; 70: 2752-2763 DOI: 10.1016/j.jacc.2017.10.006. (PMID: 29191323)
• 15 Sawaya FJ, Deutsch MA, Seiffert M. et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. JACC Cardiovasc Interv 2017; 10: 1048-1056 DOI: 10.1016/j.jcin.2017.03.004. (PMID: 28521923)
• 16 De Backer O, Pilgrim T, Simonato M. et al. Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation. Am J Cardiol 2018; 122: 1028-1035 DOI: 10.1016/j.amjcard.2018.05.044. (PMID: 30072124)
• 17 Silaschi M, Conradi L, Wendler O. et al. The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation. Catheter Cardiovasc Interv 2018; 91: 1345-1351 DOI: 10.1002/ccd.27370. (PMID: 29171730)
• 18 Tung M, Wang X, Li F. et al. A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. J Cardiol 2018; 72: 377-384 DOI: 10.1016/j.jjcc.2018.05.020. (PMID: 30064947)
• 19 Alharbi AA, Khan MZ, Osman M. et al. Transcatheter Aortic Valve Replacement vs Surgical Replacement in Patients With Pure Aortic Insufficiency. Mayo Clin Proc 2020; 95: 2655-2664 DOI: 10.1016/j.mayocp.2020.07.030. (PMID: 33276838)